News

Published on 3 May 2024 on Simply Wall St. via Yahoo Finance

With 55% ownership of the shares, Allakos Inc. (NASDAQ:ALLK) is heavily dominated by institutional...


Article preview image

Key Insights

Institutions' substantial holdings in Allakos implies that they have significant influence over the company's share priceThe top 8 shareholders own 53% of the companyUsing data from analyst forecasts alongside ownership research, one can better assess the future performance of a company

A look at the shareholders of Allakos Inc. (NASDAQ:ALLK) can tell us which group is most powerful. With 55% stake, institutions possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

NASDAQ.ALLK price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Discover US Penny Stocks To Watch In January 2025

As the U.S. stock market continues to rally, with major indices closing higher following Presiden...

Simply Wall St. · via Yahoo Finance 22 Jan 2025

3 US Penny Stocks Under $200M Market Cap To Watch

As the U.S. stock market experiences fluctuations, with technology shares recently sliding and ma...

Simply Wall St. · via Yahoo Finance 29 Nov 2024

With 55% ownership of the shares, Allakos Inc. (NASDAQ:ALLK) is heavily dominated by institutional...

Key Insights Institutions' substantial holdings in Allakos implies that they have significant inf...

Simply Wall St. via Yahoo Finance 3 May 2024

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

It was a low-key week for the biotech sector with no major updates. Regulatory and pipeline updat...

Zacks via Yahoo Finance 22 Jan 2024

Allakos (ALLK) Plummets 60% on Ending Development of Lead Drug

Shares of Allakos ALLK plunged 60.2% on Tuesday after management announced disappointing results ...

Zacks via Yahoo Finance 14 Jan 2024

Is Allakos (ALLK) Stock Outpacing Its Medical Peers This Year?

Investors interested in Medical stocks should always be looking to find the best-performing compa...

Zacks via Yahoo Finance 14 Jan 2024

Here's Why Allakos Inc. (ALLK) is Poised for a Turnaround After Losing -61.36%...

The heavy selling pressure might have exhausted for Allakos Inc. (ALLK) as it is technically in...

Zacks · via Yahoo Finance 6 Jan 2024

Following a 63% decline over last year, recent gains may please Allakos Inc. (NASDAQ:ALLK)...

Key Insights Given the large stake in the stock by institutions, Allakos' stock price might be vu...

Simply Wall St. via Yahoo Finance 6 Nov 2023

Allakos Inc. (NASDAQ:ALLK) has caught the attention of institutional investors who hold a sizeable...

Key Insights Significantly high institutional ownership implies Allakos' stock price is sensitive...

Simply Wall St. via Yahoo Finance 13 May 2023

Novavax (NVAX) to Report Q1 Earnings: What's in the Cards?

We expect investors to focus on the pipeline when Novavax, Inc. NVAX reports first-quarter 2023 r...

Zacks via Yahoo Finance 25 Apr 2023